Histological findings after angioplasty using conventional balloon, radiofrequency thermal balloon, and stent for experimental aortic coarctation

Pediatrics International

Volumn 46, Issue 1, 2004, Pages 39-47

  Ohkubo, Mataichi ^a   Takahashi, Ken ^a   Kishiro, Masahiko ^a   Akimoto, Katsumi ^a   Yamashiro, Yuichiro ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Balloon angioplasty; Coarctation of the aorta; Radiofrequency thermal balloon; Stent

Indexed keywords

GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA COARCTATION; ARTICLE; BALLOON; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DOG; EUTHANASIA; HISTOLOGY; HYPERPLASIA; INTERMETHOD COMPARISON; INTIMA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOFREQUENCY; SMOOTH MUSCLE FIBER; STENT; SURGICAL TECHNIQUE; TUNICA MEDIA;

ANGIOPLASTY, BALLOON; ANIMALS; AORTIC COARCTATION; APOPTOSIS; DOGS; ENDOTHELIN-1; RECURRENCE; STENTS; TUNICA INTIMA;

EID: 1542721837     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1328-0867.2004.t01-1-.x     Document Type: Article

References (54)

1. Sos T, Sniderman KW, Rettek-Sos B, Strupp A, Alonso DR. Percutaneous transluminal dilatation of coarctation of thoracic aorta post mortem. Lancet 1979; 3: 970-1.
2. Lock JE, Niemi T, Burke BA, Einzig S, Castaneda-Zuniga WR. Transcutaneous angioplasty of experimental aortic coarctation. Circulation 1982; 66: 1280-6.
3. Maheshwari S, Bruckheimer E, Fahey JT, Hellenbrand WE. Balloon angioplasty of postsurgical recoarctation in infants. The risk of restenosis and long-term follow-up. J. Am. Coll. Cardiol. 2000; 35: 209-13.
4. Tynan M, Finley JP, Fontes V, Hess J, Kan J. Balloon angioplasty for the treatment of native coarctation: results of valvuloplasty and angioplasty of congenital anomalies registry. Am. J. Cardiol. 1990; 65: 790-2.
5. Ino T, Nishimoto K, Kato H et al. Balloon angioplasty for aortic coarctation: report of a questionnaire survey by japanese pediatric interventional cardiology committee. Jap. Circ. J. 1997; 61: 375-83.
6. Park Y, Lucas VW, Sklansky MS, Kashani IA, Rothman A. Balloon angioplasty of native aortic coarctation in infants 3 months of age and younger. Am. Heart J. 1997; 134: 917-23.
7. Russell GA, Berry PJ, Watterson K, Dhasmana JP, Wisheart JD. Pattern of ductal tissue in coarctation of the aorta in the first three months of life. J. Thorac. Cardiovasc. Surg. 1991; 102: 596-601.
8. Ohkubo M, Ino T, Nishimoto K et al. Combined angioplasty and valvuloplasty for coexisting coarctation of the aorta and aortic stenosis in an infant. Cathet. Cardiovasc. Diagn. 1998; 45: 51-3.
9. Ohkubo M, Ino T, Shimazaki S et al. A case of coarctation of the aorta performed balloon dilatation angioplasty postmortem: histopathological findings of coarcted site. Jpn Pediatr. Circ. J. 1995; 11: 93-7.
10. Ohkubo M. Histological studies on balloon angioplasty for experimentally created coarctation of the aorta: relation between vascular response and restenosis after angioplasty. Jpn Pediatr. Circ. J. 1995; 11: 48-60.
11. Ino T, Ohkubo M, Akimoto K, Nishimoto K, Yabuta K, Watanabe M. Mechanism of balloon angioplasty in children with arterial stenosis assessed by intravascular ultrasound and angiography. Am. Heart J. 1995; 129: 132-8.
12. Ino T, Ohkubo M, Akimoto K, Nishimoto K, Yabuta K, Kawasaki S. Angiographic assessment of stretch-recoil-gain relation after balloon coarctation angioplasty and relation to later restenosis. Jpn Circ. J. 1996; 60: 102-7.
13. Ino T, Ohkubo M, Akimoto K, Nishimoto K, Yabuta K, Kawasaki S. Experimental studies on the implantation of intravascular stents in puppies: potential use for aortic coarctation and pulmonary arterial stenosis. Cardiol. Young 1994; 4: 366-72.
14. Ino T, Ohkubo M. Dilation mechanism, causes of restenosis and stenting in balloon coarctation angioplasty. Acta Paediatr. 1997; 86: 367-71.
15. Ebeid MR, Prieto LR, Latson LA. Use of balloon-expandable stents for coarctation of the aorta: initial results and intermediate-term follow-up. J. Am. Coll. Cardiol. 1997; 30: 1847-52.
16. Suarez de Lezo J, Pan M, Romero M et al. Immediate and follow-up findings after stent treatment for severe coarctation of aorta. Am. J. Cardiol. 1999; 83: 400-6.
17. Magee AG, Brzezinska-Rajszys G, Qureshi SA et al. Stent implantation for aortic coarctation and recoarctation. Heart 1999; 82: 600-6.
18. Bonan R, Paiement P, Scortichini D, Cloutier MJ, Leung TK. Coronary restenosis: evaluation of a restenosis injury index in a swine model. Am. Heart J. 1993; 126: 1334-40.
19. Humphrey WR, Simmons CA, Toombs CF, Shebuski RJ. Induction of neointimal hyperplasia by coronary angioplasty balloon overinflation: comparison of feeder pigs to Yucatan minipigs. Am. Heart J. 1994; 127: 20-31.
20. Austin G, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol. 1985; 6: 369-75.
21. Nikol S, Isner JM, Pickering G, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J. Clin. Invest. 1992; 90: 1582-92.
22. Wilcox JN. Molecular biology: insight into the causes and prevention of restenosis after arterial intervention. Am. J. Cardiol. 1993; 72: 88E-95E.
23. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am. J. Pathol. 1995; 146: 1059-64.
24. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Am. J. Pathol. 1995; 147: 251-66.
25. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-11.
26. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 1997; 95: 981-7.
27. Malik N, Francis SE, Holt CM et al. Apoptosis and cell proliferation after porcine coronary angioplasty. Circulation 1998; 98: 1657-65.
28. Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype. Circ. Res. 1999; 84: 113-21.
29. Mitchel JF, Fram DB, Aretz TA et al. Effect of low-grade conductive heating on vascular compliance during vitro balloon angioplasty. Am. Heart J. 1994; 128: 21-7.
30. Mitchel JF, McKay RG, Azrin MA, Aretz TA, Waters DD, Fram DB. Effect of low grade radiofrequency heating on arterial vasospasm in the porcine model. Cathet. Cardiovasc. Diagn. 1997; 42: 348-55.
31. Saito S, Arai H, Kim K, Aoki N. Initial clinical experiences with rescue unipolar radiofrequency thermal balloon angioplasty after abrupt or vessel closure complicating elective conventional balloon coronary angioplasty. J. Am. Coll. Cardiol. 1994; 24: 1220-8.
32. Yamashita K, Satake S, Ohira H, Ohtomo K. Radiofrequency thermal balloon coronary angioplasty: a new device for successful percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol. 1994; 23: 336-40.
33. Neya K, Lee R, Guerrero JL, Lang P, Vlahakes GJ. Experimental ablation of outflow tract muscle with a thermal balloon catheter. Circulation 1995; 91: 2445-53.
34. Abrams SE, Walsh KP, Diamond MJ, Clarkson MJ, Sibbons P. Radiofrequency thermal angioplasty maintains arterial duct patency: an experimental study. Circulation 1994; 90: 442-8.
35. Kearney M, Pieczek A, Haley L et al. Histopathology of instent restenosis in patients with peripheral artery disease. Circulation 1997; 95: 1998-2002.
36. Moreno PR, Palacios IF, Leon MN, Rhodes J, Fuster V, Fallon JT. Histopathological comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am. J. Cardiol. 1999; 84: 462-6.
37. Farb A, Sangiorgi G, Carter AJ et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44-52.
38. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J. Am. Coll. Cardiol. 2000; 35: 157-63.
39. Yanagisawa M, Kurihara H, Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
40. Ameli S, Kaul S, Castro L, Arora C, Mirea A, Shah PK. Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels. Am. J. Cardiol. 1993; 72: 1352-6.
41. Douglas SA, Louden C, Vickery-Clark LM et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty: protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ. Res. 1994; 75: 190-7.
42. Wang X, Douglas SA, Louden C, Vickery-Clark LM, Feuerstein GZ, Ohlstein EH. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat. Circ. Res. 1996; 78: 322-8.
43. Kirchengast M, Münter K. Endothelin and restenosis. Cardiovasc. Res. 1998; 39: 550-5.
44. Higashidate Y, Tsuda T, Takamuro M, Tornita H. Intravascular ultrasound imaging shortly after angioplasty of native aortic coarctation in two neonates. Pediatr. Cardiol. 1999; 20: 377-9.
45. Brzezinska-Rajszys G, Qureshi SA, Ksiazyk J et al. Middle aortic syndrome treated by stent implantation. Heart 1999; 81: 166-70.
46. Tyagi S, Sharma VP, Arora R. Stenting of the aorta for recurrent long stenosis due to Takayasu's arteritis in a child. Pediatr. Cardiol. 1999; 20: 215-7.
47. Sangiorgo G, Taylor AJ, Farb A et al. Histopathology of post-percutaneous transluminal coronary angioplasty remodeling in human coronary arteries. Am. Heart J. 1999; 138: 681-7.
48. Li G, Chen SJ, Oparil S, Chen YF, Thompson JA. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 2000; 101: 1362-5.
49. Ward MR, Sasahara T, Agrotis A, Dilley RJ, Jennings GL, Bobik A. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injury arteries. Atherosclerosis 1998; 137: 267-75.
50. Yukawa H, Miyatake SI, Saiki M et al. In vitro growth suppression of vascular smooth muscle cells using adenovirus-mediated gene transfer of a truncated form of fibroblast growth factor receptor. Atherosclerosis 1998; 141: 125-32.
51. Bilder G, Wentz T, Leadley R et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation 1999; 99: 3292-9.
52. Redington AN, Jochen W, Somerville J. Self expanding stents in congenital heart disease. Br. Heart J. 1994; 72: 378-83.
53. Cheung YF, Sanatani S, Leung MP, Human DG, Chau AKT, Culham JAG. Early and intermediate-term complications of self-expanding stents limits its potential application in children with congenital heart disease. J. Am. Coll. Cardiol. 2000; 35: 1007-15.
54. Ovaert C, McCrindle BW, Nykanen D, MacDonald C, Freedom RM, Benson LN. Balloon angioplasty of native coarctation. clinical outcomes and predictors of success. J. Am. Coll. Cardiol. 2000; 35: 988-96.